# Priftin

NDC: 0088-2102
Generic name: rifapentine
Labeler / Manufacturer: sanofi-aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170208

FDA application: NDA021024

## Active ingredients

- RIFAPENTINE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0088-2102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0088-2102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a64fb70-b85e-43d9-8bcd-7e893f568ae1